About: Imatinib mesylate suppresses bone metastases of breast cancer by inhibiting osteoclasts through the blockade of c-Fms signals     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific journal article

AttributesValues
rdf:type
description
  • artículu científicu espublizáu en 2009 (ast)
  • vedecký článok (publikovaný 2009/01/01) (sk)
  • vědecký článek publikovaný v roce 2009 (cs)
  • wetenschappelijk artikel (gepubliceerd op 2009/01/01) (nl)
  • مقالة علمية (نشرت عام 2009) (ar)
  • article scientifique publié en 2009 (fr)
  • 2009 թվականի հունվարին հրատարակված գիտական հոդված (hy)
  • наукова стаття, опублікована в січні 2009 (uk)
  • 2009 թուականի Յունուարին հրատարակուած գիտական յօդուած (hyw)
  • im Januar 2009 veröffentlichter wissenschaftlicher Artikel (de)
  • scientific journal article (en)
publication date
publication date
language of work or name
language of work or name
cites work
cites work
author name string
OpenCitations bibliographic resource ID
OpenCitations bibliographic resource ID
author name string
  • Hiroaki Nakamura
  • Toru Hiraga
OpenCitations bibliographic resource ID
  • 3001089
rdfs:label
  • Imatinib mesylate suppresses bone metastases of breast cancer by inhibiting osteoclasts through the blockade of c-Fms signals (en)
  • Imatinib mesylate suppresses bone metastases of breast cancer by inhibiting osteoclasts through the blockade of c-Fms signals (nl)
  • Imatinib mesylate suppresses bone metastases of breast cancer by inhibiting osteoclasts through the blockade of c-Fms signals (ast)
skos:prefLabel
  • Imatinib mesylate suppresses bone metastases of breast cancer by inhibiting osteoclasts through the blockade of c-Fms signals (en)
  • Imatinib mesylate suppresses bone metastases of breast cancer by inhibiting osteoclasts through the blockade of c-Fms signals (nl)
  • Imatinib mesylate suppresses bone metastases of breast cancer by inhibiting osteoclasts through the blockade of c-Fms signals (ast)
name
  • Imatinib mesylate suppresses bone metastases of breast cancer by inhibiting osteoclasts through the blockade of c-Fms signals (en)
  • Imatinib mesylate suppresses bone metastases of breast cancer by inhibiting osteoclasts through the blockade of c-Fms signals (nl)
  • Imatinib mesylate suppresses bone metastases of breast cancer by inhibiting osteoclasts through the blockade of c-Fms signals (ast)
title
title
  • Imatinib mesylate suppresses bone metastases of breast cancer by inhibiting osteoclasts through the blockade of c-Fms signals (en)
page(s)
page(s)
  • 215–222
instance of
instance of
main subject
main subject
PubMed ID
PubMed ID
PubMed ID
  • 18814279
published in
published in
issue
volume
issue
  • 1
volume
  • 124
DOI
DOI
DOI
  • 10.1002/IJC.23903
ResearchGate publication ID
ResearchGate publication ID
  • 23279949
is about of
is cites work of
is cites work of
Faceted Search & Find service v1.16.117 as of May 05 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software